| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
3e-16 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-14 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
| mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |